RecruitingNCT06831903

Radiotherapy of Head and Neck Cancer With SIB

Simultaneous Integrated Boost in the Primary and Adjuvant Therapy of Head and Neck Cancer: Quality Control Registry Prospective Longitudinal Obervation Trial

Sponsor

Wuerzburg University Hospital

Enrollment

750 participants

Start Date

May 21, 2019

Study Type

OBSERVATIONAL

Conditions

Radiotherapy Side Effect Quality of Life (QOL)Head and Neck Cancer Radiotherapy, Conformal (IMRT)

Summary

Title: Simultaneous Integrated Boost in Primary and Adjuvant Therapy of Head and Neck Tumors: Quality Control Registry Prospective Longitudinal Observational Study Short Title: Radiotherapy for Head and Neck Tumors with SIB Objective: To evaluate the efficacy and safety of definitive and adjuvant radio(chemo)therapy with simultaneous integrated boost (SIB) in patients with head and neck cancers. The study aims to assess local and regional control, overall survival, metastasis-free survival, therapy-related toxicities, and quality of life. Study Design: A prospective, longitudinal, non-interventional registry study documenting real-world outcomes and quality measures of therapy applied according to existing clinical guidelines.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data on quality of life and symptoms in patients with head and neck cancer who are receiving radiation therapy (with or without chemotherapy) at a university hospital. Researchers want to understand how treatment affects patients' wellbeing over time. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with a malignant head and neck tumor confirmed by biopsy - You are receiving definitive or post-surgery radiation treatment at the University Hospital Würzburg **You may NOT be eligible if...** - You are unable or unwilling to provide informed consent - You have a mental or physical condition that prevents you from completing questionnaires - Your doctor believes participation would not be appropriate for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.